TY - JOUR
T1 - Machine learning model to predict recurrent ulcer bleeding in patients with history of idiopathic gastroduodenal ulcer bleeding
AU - Wong, Grace Lai Hung
AU - Ma, Andy Jinhua
AU - Deng, Huiqi
AU - Ching, Jessica Yuet Ling
AU - Wong, Vincent Wai Sun
AU - Tse, Yee Kit
AU - Yip, Terry Cheuk Fung
AU - Lau, Louis Ho Shing
AU - Liu, Henry Hin Wai
AU - Leung, Chi Man
AU - Tsang, Steven Woon Choy
AU - Chan, Chun Wing
AU - Lau, James Yun Wong
AU - YUEN, Pong Chi
AU - Chan, Francis Ka Leung
N1 - Funding Information:
This study was funded in part by the General Research Fund – Research Grant Council (project reference number: 477213) to Grace Wong.
PY - 2019/4
Y1 - 2019/4
N2 - Background: Patients with a history of Helicobacter pylori–negative idiopathic bleeding ulcers have an increased risk of recurring ulcer complications. Aim: To build a machine learning model to identify patients at high risk for recurrent ulcer bleeding. Methods: Data from a retrospective cohort of 22 854 patients (training cohort) diagnosed with peptic ulcer disease in 2007-2016 were analysed to build a model (IPU-ML) to predict recurrent ulcer bleeding. We tested the IPU-ML in all patients with a diagnosis of gastrointestinal bleeding (n = 1265) in 2008-2015 from a different catchment population (independent validation cohort). Any co-morbid conditions which had occurred in >1% of study population were eligible as predictors. Results: Recurrent ulcer bleeding developed in 4772 patients (19.5%) in the training cohort, during a median follow-up period of 2.7 years. IPU-ML model built on six parameters (age, baseline haemoglobin, and presence of gastric ulcer, gastrointestinal diseases, malignancies, and infections) identified patients with bleeding recurrence within 1 year with an area under the receiver operating characteristic curve (AUROC) of 0.648. When we set the IPU-ML cutoff value at 0.20, 27.5% of patients were classified as high risk for rebleeding with a sensitivity of 41.4%, specificity of 74.6%, and a negative predictive value of 91.1%. In the validation cohort, the IPU-ML identified patients with a recurrence ulcer bleeding within 1 year with an AUROC of 0.775, and 84.3% of overall accuracy. Conclusion: We developed a machine-learning model to identify those patients with a history of idiopathic gastroduodenal ulcer bleeding who are not at high risk for recurrent ulcer bleeding.
AB - Background: Patients with a history of Helicobacter pylori–negative idiopathic bleeding ulcers have an increased risk of recurring ulcer complications. Aim: To build a machine learning model to identify patients at high risk for recurrent ulcer bleeding. Methods: Data from a retrospective cohort of 22 854 patients (training cohort) diagnosed with peptic ulcer disease in 2007-2016 were analysed to build a model (IPU-ML) to predict recurrent ulcer bleeding. We tested the IPU-ML in all patients with a diagnosis of gastrointestinal bleeding (n = 1265) in 2008-2015 from a different catchment population (independent validation cohort). Any co-morbid conditions which had occurred in >1% of study population were eligible as predictors. Results: Recurrent ulcer bleeding developed in 4772 patients (19.5%) in the training cohort, during a median follow-up period of 2.7 years. IPU-ML model built on six parameters (age, baseline haemoglobin, and presence of gastric ulcer, gastrointestinal diseases, malignancies, and infections) identified patients with bleeding recurrence within 1 year with an area under the receiver operating characteristic curve (AUROC) of 0.648. When we set the IPU-ML cutoff value at 0.20, 27.5% of patients were classified as high risk for rebleeding with a sensitivity of 41.4%, specificity of 74.6%, and a negative predictive value of 91.1%. In the validation cohort, the IPU-ML identified patients with a recurrence ulcer bleeding within 1 year with an AUROC of 0.775, and 84.3% of overall accuracy. Conclusion: We developed a machine-learning model to identify those patients with a history of idiopathic gastroduodenal ulcer bleeding who are not at high risk for recurrent ulcer bleeding.
UR - http://www.scopus.com/inward/record.url?scp=85061596602&partnerID=8YFLogxK
U2 - 10.1111/apt.15145
DO - 10.1111/apt.15145
M3 - Journal article
C2 - 30761584
AN - SCOPUS:85061596602
SN - 0269-2813
VL - 49
SP - 912
EP - 918
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 7
ER -